# OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate

> **NCT04573647** · — · UNKNOWN · sponsor: **Sight Medical Doctors PLLC** · enrollment: 10 (estimated)

## Conditions studied

- Neurotrophic Ulcer
- Neurotrophic Keratitis
- Neurotrophic Corneal Ulcer
- Neurotrophic Keratoconjunctivitis

## Interventions

- **DRUG:** Cenegermin-Bkbj 0.002% Ophthalmic Solution [OXERVATE]

## Key facts

- **NCT ID:** NCT04573647
- **Lead sponsor:** Sight Medical Doctors PLLC
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04573647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04573647, "OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04573647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*